Published • loading... • Updated
L'Oreal says weight loss drugs are impacting beauty and skin care sales
The company is testing products with Galderma as 7.7% quarterly sales growth beat analyst expectations, executives said.
Summary by BBC News
4 Articles
4 Articles
L'Oréal, a major French cosmetics company, states that the trend of using weight-loss drugs is affecting consumer behavior in purchasing beauty products, especially skincare products.
Nicolas Hieronimus, CEO of cosmetics giant L'Oréal, stated that the increasing popularity of weight-loss drugs like Ozempic and Wegovy has impacted consumption in the beauty and especially skincare sectors. The company is developing products to address skin sagging associated with rapid weight loss.
L'Oreal's executive director claims that the use of LPG-1 is "a very important phenomenon" for his company.
Coverage Details
Total News Sources4
Leaning Left0Leaning Right1Center1Last UpdatedBias Distribution50% Center, 50% Right
Bias Distribution
- 50% of the sources are Center, 50% of the sources lean Right
50% Right
C 50%
R 50%
Factuality
To view factuality data please Upgrade to Premium
